Can a light beam clear stubborn blackheads?
NCT ID NCT06909344
First seen Aug 18, 2026 · Last updated Aug 19, 2026 · Updated 1 time
Summary
This trial tests whether a 577-nm diode laser can safely reduce non-inflammatory acne, such as blackheads and whiteheads. Half of each participant's face receives laser treatment, while the other half serves as an untreated control. The study includes adults aged 18-40 with at least 10 comedonal lesions on each side of the face. The main goal is to see if the laser decreases the number of comedones.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- 577-nm diode laser treatment
- What this could lead to
- If effective, this laser could offer a non-invasive, drug-free option for reducing comedonal acne.
- What could go wrong
- This is a small, early-stage trial, and results may not apply to all acne types. Possible side effects include redness or irritation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
50 people
The number who actually took part.
- Started
-
Mar 2025
- Finished
-
Feb 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 40 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with acne comedones * Patients' ages range from 18-40 years. * Minimum 10 comedonal lesions on both half of the face Exclusion Criteria: * Patients with systemic disease interfere with healing. * Patients with Photosensitivity. * Pregnant or lactating females. * Previous topical, systemic, laser, surgical treatment and comedogenic drugs in the last 3 months. * Skin cancer or suspicious lesions.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acne are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Azhar Assuit university hospital
Asyut, Assuit, 71511, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a vaccine clear up severe teen acne?
- A new serum aims to clear acne and boost skin confidence
- Can coconut oil calm acne without irritating sensitive skin?
- Acne fighters: ubiquinol and pomegranate peel extract put to the test
- Gut bacteria cocktail could clear acne without pills or creams
- New laser shows promise for wrinkle reduction in clinical trial